FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

per Kjersem, Janne B, Skovlund, Eva, Ikdahl, Tone, Guren, Tormod, Kersten, Christian, Dalsgaard, Astrid M, Yilmaz, Mette K, Fokstuen, Tone, Tveit, Kjell M, Kure, Elin H
Publicat 2014

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

per Schultz, Nicolai A., Christensen, Ib J., Werner, Jens, Giese, Nathalia, Jensen, Benny V., Larsen, Ole, Bjerregaard, Jon K., Pfeiffer, Per, Calatayud, Dan, Nielsen, Svend E., Yilmaz, Mette K., Holländer, Niels H., Wøjdemann, Morten, Bojesen, Stig E., Nielsen, Kaspar R., Johansen, Julia S.
Publicat 2013